MovDisordV3, Main, Exploration, bibRecord, 005B01

Severe evening dyskinesias in advanced Parkinson's disease: Clinical description, relation to plasma levodopa, and treatment

Identifieur interne : 005B01 ( Main/Exploration ); précédent : 005B00; suivant : 005B02

Severe evening dyskinesias in advanced Parkinson's disease: Clinical description, relation to plasma levodopa, and treatment

Auteurs : Thomas R. Zimmerman Jr. [États-Unis] ; Jacob I. Sage [États-Unis] ; Anthony E. Lang [Canada] ; Mark [États-Unis]

Source :

Movement Disorders [ 0885-3185 ] ; 1994.

RBID : ISTEX:13157136085C969EE4830BC362C6C00615ACB2B4

English descriptors

KwdEn :
- Aged, Antiparkinson Agents (administration & dosage), Antiparkinson Agents (adverse effects), Antiparkinson Agents (pharmacokinetics), Bromocriptine (administration & dosage), Carbidopa (administration & dosage), Carbidopa (adverse effects), Carbidopa (pharmacokinetics), Chorea (blood), Chorea (chemically induced), Chorea (diagnosis), Circadian Rhythm (drug effects), Delayed-Action Preparations, Dose-Response Relationship, Drug, Drug Administration Schedule, Drug Combinations, Drug Therapy, Combination, Dyskinesia, Drug-Induced (blood), Dyskinesia, Drug-Induced (diagnosis), Dyskinesia, Drug-Induced (drug therapy), Dyskinesias, Dystonia (blood), Dystonia (chemically induced), Dystonia (diagnosis), Dystonia (drug therapy), Evening, Female, Humans, Levodopa (administration & dosage), Levodopa (adverse effects), Levodopa (pharmacokinetics), Low dopa dyskinesias, Male, Middle Aged, Neurologic Examination (drug effects), Parkinson Disease (blood), Parkinson Disease (diagnosis), Parkinson Disease (drug therapy), Parkinson's disease.
MESH :
- chemical , administration & dosage : Antiparkinson Agents, Bromocriptine, Carbidopa, Levodopa.
- chemical , adverse effects : Antiparkinson Agents, Carbidopa, Levodopa.
- chemical , pharmacokinetics : Antiparkinson Agents, Carbidopa, Levodopa.
- blood : Chorea, Dyskinesia, Drug-Induced, Dystonia, Parkinson Disease.
- chemically induced : Chorea, Dystonia.
- diagnosis : Chorea, Dyskinesia, Drug-Induced, Dystonia, Parkinson Disease.
- drug effects : Circadian Rhythm, Neurologic Examination.
- drug therapy : Dyskinesia, Drug-Induced, Dystonia, Parkinson Disease.
- Aged, Delayed-Action Preparations, Dose-Response Relationship, Drug, Drug Administration Schedule, Drug Combinations, Drug Therapy, Combination, Female, Humans, Male, Middle Aged.

Abstract

We report four patients with Parkinson's disease who had an unusual pattern of severe chorea and dystonia in the evenings only. The temporal pattern of abnormal movements and simultaneous monitoring of plasma levodopa and clinical state were consistent with dyskinesias associated with subtherapeutic (low dopa dyskinesias) rather than peak concentrations of levodopa (high dopa dyskinesias). In two patients, addition of a direct‐acting dopamine receptor agonist was helpful in ameliorating this complication of anitparkinson therapy.

Url:

https://api.istex.fr/document/13157136085C969EE4830BC362C6C00615ACB2B4/fulltext/pdf

DOI: 10.1002/mds.870090208

Affiliations:

Le document en format XML

<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Severe evening dyskinesias in advanced Parkinson's disease: Clinical description, relation to plasma levodopa, and treatment</title>
<author><name sortKey="Zimmerman Jr, Thomas R" sort="Zimmerman Jr, Thomas R" uniqKey="Zimmerman Jr T" first="Thomas R." last="Zimmerman Jr.">Thomas R. Zimmerman Jr.</name>
</author>
<author><name sortKey="Sage, Jacob I" sort="Sage, Jacob I" uniqKey="Sage J" first="Jacob I." last="Sage">Jacob I. Sage</name>
</author>
<author><name sortKey="Lang, Anthony E" sort="Lang, Anthony E" uniqKey="Lang A" first="Anthony E." last="Lang">Anthony E. Lang</name>
</author>
<author><name sortKey="Mark" sort="Mark" uniqKey="Mark" last="Mark">Mark</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:13157136085C969EE4830BC362C6C00615ACB2B4</idno>
<date when="1994" year="1994">1994</date>
<idno type="doi">10.1002/mds.870090208</idno>
<idno type="url">https://api.istex.fr/document/13157136085C969EE4830BC362C6C00615ACB2B4/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">003151</idno>
<idno type="wicri:Area/Istex/Curation">003151</idno>
<idno type="wicri:Area/Istex/Checkpoint">003E36</idno>
<idno type="wicri:doubleKey">0885-3185:1994:Zimmerman Jr T:severe:evening:dyskinesias</idno>
<idno type="wicri:source">PubMed</idno>
<idno type="RBID">pubmed:8196678</idno>
<idno type="wicri:Area/PubMed/Corpus">004B37</idno>
<idno type="wicri:Area/PubMed/Curation">004B37</idno>
<idno type="wicri:Area/PubMed/Checkpoint">004A69</idno>
<idno type="wicri:Area/Ncbi/Merge">004909</idno>
<idno type="wicri:Area/Ncbi/Curation">004909</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">004909</idno>
<idno type="wicri:doubleKey">0885-3185:1994:Zimmerman T:severe:evening:dyskinesias</idno>
<idno type="wicri:Area/Main/Merge">008C92</idno>
<idno type="wicri:Area/Main/Curation">005B01</idno>
<idno type="wicri:Area/Main/Exploration">005B01</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Severe evening dyskinesias in advanced Parkinson's disease: Clinical description, relation to plasma levodopa, and treatment</title>
<author><name sortKey="Zimmerman Jr, Thomas R" sort="Zimmerman Jr, Thomas R" uniqKey="Zimmerman Jr T" first="Thomas R." last="Zimmerman Jr.">Thomas R. Zimmerman Jr.</name>
<affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Neurology, University of Medicine and Dentistry of New Jersey‐Robert Wood Johnson Medical School, New Brunswick, New Jersey</wicri:regionArea>
<placeName><region type="state">New Jersey</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Sage, Jacob I" sort="Sage, Jacob I" uniqKey="Sage J" first="Jacob I." last="Sage">Jacob I. Sage</name>
<affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Neurology, University of Medicine and Dentistry of New Jersey‐Robert Wood Johnson Medical School, New Brunswick, New Jersey</wicri:regionArea>
<placeName><region type="state">New Jersey</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Lang, Anthony E" sort="Lang, Anthony E" uniqKey="Lang A" first="Anthony E." last="Lang">Anthony E. Lang</name>
<affiliation wicri:level="4"><country xml:lang="fr">Canada</country>
<wicri:regionArea>Division of Neurology and the Playfair Neurosciences Unit, University of Toronto, The Toronto Hospital, Toronto, Ontario</wicri:regionArea>
<orgName type="university">Université de Toronto</orgName>
<placeName><settlement type="city">Toronto</settlement>
<region type="state">Ontario</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Mark" sort="Mark" uniqKey="Mark" last="Mark">Mark</name>
<affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Neurology, University of Medicine and Dentistry of New Jersey‐Robert Wood Johnson Medical School, New Brunswick, New Jersey</wicri:regionArea>
<placeName><region type="state">New Jersey</region>
</placeName>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j">Movement Disorders</title>
<title level="j" type="abbrev">Mov. Disord.</title>
<idno type="ISSN">0885-3185</idno>
<idno type="eISSN">1531-8257</idno>
<imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<pubPlace>Hoboken</pubPlace>
<date type="published" when="1994">1994</date>
<biblScope unit="vol">9</biblScope>
<biblScope unit="issue">2</biblScope>
<biblScope unit="page" from="173">173</biblScope>
<biblScope unit="page" to="177">177</biblScope>
</imprint>
<idno type="ISSN">0885-3185</idno>
</series>
<idno type="istex">13157136085C969EE4830BC362C6C00615ACB2B4</idno>
<idno type="DOI">10.1002/mds.870090208</idno>
<idno type="ArticleID">MDS870090208</idno>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Aged</term>
<term>Antiparkinson Agents (administration & dosage)</term>
<term>Antiparkinson Agents (adverse effects)</term>
<term>Antiparkinson Agents (pharmacokinetics)</term>
<term>Bromocriptine (administration & dosage)</term>
<term>Carbidopa (administration & dosage)</term>
<term>Carbidopa (adverse effects)</term>
<term>Carbidopa (pharmacokinetics)</term>
<term>Chorea (blood)</term>
<term>Chorea (chemically induced)</term>
<term>Chorea (diagnosis)</term>
<term>Circadian Rhythm (drug effects)</term>
<term>Delayed-Action Preparations</term>
<term>Dose-Response Relationship, Drug</term>
<term>Drug Administration Schedule</term>
<term>Drug Combinations</term>
<term>Drug Therapy, Combination</term>
<term>Dyskinesia, Drug-Induced (blood)</term>
<term>Dyskinesia, Drug-Induced (diagnosis)</term>
<term>Dyskinesia, Drug-Induced (drug therapy)</term>
<term>Dyskinesias</term>
<term>Dystonia (blood)</term>
<term>Dystonia (chemically induced)</term>
<term>Dystonia (diagnosis)</term>
<term>Dystonia (drug therapy)</term>
<term>Evening</term>
<term>Female</term>
<term>Humans</term>
<term>Levodopa (administration & dosage)</term>
<term>Levodopa (adverse effects)</term>
<term>Levodopa (pharmacokinetics)</term>
<term>Low dopa dyskinesias</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Neurologic Examination (drug effects)</term>
<term>Parkinson Disease (blood)</term>
<term>Parkinson Disease (diagnosis)</term>
<term>Parkinson Disease (drug therapy)</term>
<term>Parkinson's disease</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Antiparkinson Agents</term>
<term>Bromocriptine</term>
<term>Carbidopa</term>
<term>Levodopa</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en"><term>Antiparkinson Agents</term>
<term>Carbidopa</term>
<term>Levodopa</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="pharmacokinetics" xml:lang="en"><term>Antiparkinson Agents</term>
<term>Carbidopa</term>
<term>Levodopa</term>
</keywords>
<keywords scheme="MESH" qualifier="blood" xml:lang="en"><term>Chorea</term>
<term>Dyskinesia, Drug-Induced</term>
<term>Dystonia</term>
<term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" qualifier="chemically induced" xml:lang="en"><term>Chorea</term>
<term>Dystonia</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Chorea</term>
<term>Dyskinesia, Drug-Induced</term>
<term>Dystonia</term>
<term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" qualifier="drug effects" xml:lang="en"><term>Circadian Rhythm</term>
<term>Neurologic Examination</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Dyskinesia, Drug-Induced</term>
<term>Dystonia</term>
<term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Aged</term>
<term>Delayed-Action Preparations</term>
<term>Dose-Response Relationship, Drug</term>
<term>Drug Administration Schedule</term>
<term>Drug Combinations</term>
<term>Drug Therapy, Combination</term>
<term>Female</term>
<term>Humans</term>
<term>Male</term>
<term>Middle Aged</term>
</keywords>
</textClass>
<langUsage><language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">We report four patients with Parkinson's disease who had an unusual pattern of severe chorea and dystonia in the evenings only. The temporal pattern of abnormal movements and simultaneous monitoring of plasma levodopa and clinical state were consistent with dyskinesias associated with subtherapeutic (low dopa dyskinesias) rather than peak concentrations of levodopa (high dopa dyskinesias). In two patients, addition of a direct‐acting dopamine receptor agonist was helpful in ameliorating this complication of anitparkinson therapy.</div>
</front>
</TEI>
<affiliations><list><country><li>Canada</li>
<li>États-Unis</li>
</country>
<region><li>New Jersey</li>
<li>Ontario</li>
</region>
<settlement><li>Toronto</li>
</settlement>
<orgName><li>Université de Toronto</li>
</orgName>
</list>
<tree><country name="États-Unis"><region name="New Jersey"><name sortKey="Zimmerman Jr, Thomas R" sort="Zimmerman Jr, Thomas R" uniqKey="Zimmerman Jr T" first="Thomas R." last="Zimmerman Jr.">Thomas R. Zimmerman Jr.</name>
</region>
<name sortKey="Mark" sort="Mark" uniqKey="Mark" last="Mark">Mark</name>
<name sortKey="Sage, Jacob I" sort="Sage, Jacob I" uniqKey="Sage J" first="Jacob I." last="Sage">Jacob I. Sage</name>
</country>
<country name="Canada"><region name="Ontario"><name sortKey="Lang, Anthony E" sort="Lang, Anthony E" uniqKey="Lang A" first="Anthony E." last="Lang">Anthony E. Lang</name>
</region>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Exploration

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 005B01 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 005B01 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     ISTEX:13157136085C969EE4830BC362C6C00615ACB2B4
   |texte=   Severe evening dyskinesias in advanced Parkinson's disease: Clinical description, relation to plasma levodopa, and treatment
}}

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024

Movement Disorders (revue)

Severe evening dyskinesias in advanced Parkinson's disease: Clinical description, relation to plasma levodopa, and treatment

Severe evening dyskinesias in advanced Parkinson's disease: Clinical description, relation to plasma levodopa, and treatment

Source :

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

	Movement Disorders (revue)
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.